Bayer Secures EU Approval for Lynkuet Menopause Treatment
Bayer has secured regulatory clearance in both the United States and the European Union for Lynkuet, a non-hormonal therapy for vasomotor symptoms (VMS), marking...
Lilly to Build $3B Manufacturing Facility in Netherlands
Eli Lilly and Company is investing $3 billion to build a new manufacturing facility in Katwijk, the Netherlands, within the Leiden Bio Science Park....
AstraZeneca Secures EU Approval for Koselugo to Treat NF1 PN
Alexion, an AstraZeneca rare disease, has received EU approval for Koselugo (selumetinib), its oral, selective MEK inhibitor, to treat symptomatic, inoperable plexiform neurofibromas (PN)...
UK Grants Pharma Firms Early Access to Aligned Pathway
Pharmaceutical companies producing qualifying medicines can now benefit from an accelerated approvals pathway, gaining access significantly earlier than initially expected.
The Medicines and Healthcare products...
ABPI Launches Manifesto to Advance Scottish Pharma Sector
The Association of the British Pharmaceutical Industry (ABPI) has released its manifesto for the Scottish Government, calling for political leaders to act now and...
Pharmaceutical Tariff Agreed at 15% Under US-EU Trade Deal
Pharmaceutical tariffs between the European Union and the United States will now be limited at 15% under the terms of the latest trade agreement,...
Lupin, Sandoz Collab to Commercialise Biosimilar Ranibizumab
Lupin partners with Sandoz Group AG to commercialise and market its biosimilar ranibizumab worldwide. The product will be commercialised in a number of markets,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...